Thomas Joder

Background

About Thomas Joder

GMT Science improves the clinical management of chronic diseases thanks to reliable, clinical-grade gut microbiome analysis. Mounting evidence points to changes in the composition and functionality of the gut microbiota in a growing list of medical conditions such as liver and bowel diseases, diabetes, obesity, mental disorders and cancer. This offers opportunities to use microbiome-based biomarkers in clinical management. However, clinicians are still in need of reliable solutions to assess the microbiome of their patients for disease prevention, monitoring and prognosis. GMT Science leverages standardized analytical procedures, high-quality quantitative metagenomics and proprietary AI-based algorithms to bring robust and reproducible microbiome analysis to medical laboratories. Our microbiome analysis software is a CE-marked medical device for in vitro diagnostic. By providing precise metrics and reference values to medical labs, GMT Science allows physicians to take the patient’s microbiome into account in their clinical practice.